Miguel A. Rodrigues is an Assistant Professor of the Chemical Engineering Department of the Instituto Superior Técnico (University of Lisbon) and a researcher of the Centro de Química Estrutural. He graduated in Biological Engineering (UAlg) and received his Ph.D in Chemical Engineering (Técnico) in 2006. His Ph.D. dissertation was on “Production of particles for controlled release of pharmaceutical substances using supercritical fluids”. Before joining Técnico as a research fellow (in 2009) he was an invited scientist at the University of Texas at Austin, where he developed research on “Controlled freezing processes for producing stable protein particles” sponsored by Pfizer. Since then, his work has explored these two fields of Chemical Technology, namely, supercritical systems to improve stability and delivery of pharmaceutical products and novel routes and methods for cryo-processing of proteins and cells to potentiate emerging therapies. His research has motivated several collaborations in Europe and overseas, with colleagues from academia and industry. He has been invited to give seminars in R&D centres of major pharmaceutical companies and in international conferences. Some of his distinguished works can illustrate his current research interests: Production of particles for controlled release of pharmaceutical substances using supercritical fluids. - FCT/CUF distinction in Best 2007 Ph.D thesis with industrial application. Super-minocycline - The stable, high-temperature resistant, novel minocycline polymorph - Solvay/Hovione distinction in 2011 innovation challenge (SHIC). A method for Predicting Proteins Frozen Storage Stability - Jansen prize for excellence in Ph.D. education from the American Association of Pharmaceutical Scientists in AAPS2015 conference (to my student Monica Rosa). Miguel A. Rodrigues is author of several publications, patents and a co-founder of Smartfreez, a Start-up company that licensed IP from Técnico and is now shaping cryopreservation methods of major biopharma industries.